| P50 | author | Jan L Ceuppens | Q45773073 |
| P2093 | author name string | Stefaan W Van Gool | |
| | Bert Verbinnen | |
| P2860 | cites work | Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse | Q24290693 |
| | Viral immune evasion due to persistence of activated T cells without effector function | Q24646943 |
| | Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 |
| | Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 |
| | Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 |
| | Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? | Q28207052 |
| | The B7 family revisited | Q28240070 |
| | The inhibitory cytokine IL-35 contributes to regulatory T-cell function | Q28258462 |
| | Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade | Q28564305 |
| | Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 | Q28591451 |
| | A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism | Q29614266 |
| | Regulatory T cells and immune tolerance | Q29616864 |
| | X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy | Q29619109 |
| | The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 | Q29619324 |
| | A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 |
| | CTLA-4 control over Foxp3+ regulatory T cell function | Q29619413 |
| | PD-L1 regulates the development, maintenance, and function of induced regulatory T cells | Q30080038 |
| | The impact of T cell intrinsic antigen adaptation on peripheral immune tolerance | Q33260750 |
| | Mechanisms of tolerance induction: blockade of co-stimulation. | Q33772256 |
| | Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation | Q33814943 |
| | Mixed chimerism and transplantation tolerance | Q34131999 |
| | Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion | Q42941965 |
| | T cell apoptosis by tryptophan catabolism | Q44137068 |
| | CTLA-4-Ig regulates tryptophan catabolism in vivo. | Q44170968 |
| | The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo | Q44355387 |
| | Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys | Q44493665 |
| | OX40 controls islet allograft tolerance in CD154 deficient mice by regulating FOXP3+ Tregs | Q44892329 |
| | Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | Q44986020 |
| | Beneficial effects of costimulatory blockade with anti-inducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse | Q45183367 |
| | Costimulation blockade with belatacept in renal transplantation | Q46569880 |
| | Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity. | Q47725914 |
| | Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. | Q51541351 |
| | Induction of regulatory cells and control of cellular but not vascular rejection by costimulation blockade in hamster-to-rat heart xenotransplantation. | Q51800713 |
| | Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: the interplay of clonal anergy and immune regulation. | Q51815669 |
| | OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival. | Q51823618 |
| | ICOS-Dependent and -independent functions of memory CD4 T cells in allograft rejection. | Q51966823 |
| | Role of the ICOS-B7h costimulatory pathway in the pathophysiology of chronic allograft rejection. | Q51992235 |
| | Contribution of regulatory T cells and effector T cell deletion in tolerance induction by costimulation blockade. | Q53467808 |
| | CTLA-4 engagement and regulatory CD4+CD25+ T cells independently control CD8+-mediated responses under costimulation blockade. | Q53626991 |
| | Critical role of OX40 in CD28 and CD154-independent rejection. | Q53905524 |
| | Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. | Q54073234 |
| | The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis | Q56903575 |
| | When ligand becomes receptor--tolerance via B7 signaling on DCs | Q56904184 |
| | Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment | Q56906119 |
| | Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production | Q56906817 |
| | Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways | Q56908985 |
| | T cell tolerance by clonal elimination in the thymus | Q56922465 |
| | Pretransplant Donor Peripheral Blood Mononuclear Cells Infusion Induces Transplantation Tolerance by Generating Regulatory T Cells | Q57702909 |
| | Positive and negative selection of T cells | Q34157557 |
| | CTLA4Ig promotes the induction of hematopoietic chimerism and tolerance independently of Indoleamine-2,3-dioxygenase | Q34356219 |
| | CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates | Q34433847 |
| | CTLA-4 (CD152) and its involvement in autoimmune disease | Q34560446 |
| | Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. | Q34569888 |
| | The B7-CD28 superfamily | Q34575331 |
| | Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses | Q34650346 |
| | IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation | Q34674495 |
| | OX40 ligand shuts down IL-10-producing regulatory T cells | Q35016533 |
| | T cell anergy | Q35019694 |
| | Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells | Q35630644 |
| | Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning | Q35679173 |
| | Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients | Q35824531 |
| | Regulatory T cells and mechanisms of immune system control | Q35852343 |
| | Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection | Q35939463 |
| | OX40 costimulation turns off Foxp3+ Tregs. | Q36007580 |
| | Peripheral tolerance of CD8 T lymphocytes | Q36076297 |
| | Regulation of immune and autoimmune responses by ICOS-B7h interaction | Q36115747 |
| | Regulation of immunity by self-reactive T cells | Q36148406 |
| | CTLA-4 is a second receptor for the B cell activation antigen B7 | Q36230356 |
| | Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance | Q36364608 |
| | In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 |
| | Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance | Q36401145 |
| | The induction and maintenance of T cell anergy | Q36438018 |
| | Regulation of the T cell response | Q36643790 |
| | The Foxp3+ regulatory T cell: a jack of all trades, master of regulation | Q37088900 |
| | CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance | Q37106789 |
| | Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. | Q37256978 |
| | TLR agonists prevent the establishment of allogeneic hematopoietic chimerism in mice treated with costimulation blockade. | Q37290406 |
| | T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo | Q37308435 |
| | Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. | Q37382702 |
| | The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. | Q39785791 |
| | Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. | Q40459668 |
| | CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. | Q40658295 |
| | T-cell-receptor affinity and thymocyte positive selection | Q41192128 |
| | The CD40 pathway in allograft rejection, acceptance, and tolerance | Q41642375 |
| | Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand | Q42767299 |
| | Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin | Q42936502 |
| P433 | issue | 4 | |
| P304 | page(s) | 497-509 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Immunotherapy | Q18713038 |
| P1476 | title | Blocking costimulatory pathways: prospects for inducing transplantation tolerance | |
| P478 | volume | 2 | |